Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (51-60 of 280) with videos related to

Pageof 28
Sort By:
Annals of Hematology|June 27, 2025
Effectiveness of venetoclax based therapy in t(11;14) multiple myeloma with extensive extramedullary disease: a case reportKerstin Brinkert, Bernd Heinrich, Annamaria Brioli, et al.
Annals of Hematology|October 27, 2020
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrowNils W Engel, Jochim Reinert, Nora M Borchert, et al.
GMS Hygiene and Infection Control|November 22, 2018
Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncologyClaas Baier, Christin Linderkamp, Andreas Beilken, et al.
Experimental Hematology|January 26, 2010
Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemiaMichael Heuser, Gyeongsin Park, Yeonsook Moon, et al.
Leukemia & Lymphoma|September 24, 2020
Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel reviewJorge E Cortes, Anna Candoni, Richard E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factorFrederik Damm, Kathrin Lange, Michael Heuser, et al.
Experimental Hematology|April 1, 2008
Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3Bob Argiropoulos, Lars Palmqvist, Eric Yung, et al.
Haematologica|September 2, 2011
Rare occurrence of DNMT3A mutations in myelodysplastic syndromesFelicitas Thol, Claudia Winschel, Andrea Lüdeking, et al.
International Journal of Molecular Sciences|October 24, 2018
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q DeletionSimone Feurstein, Kathrin Thomay, Winfried Hofmann, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 20, 2023
A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemiaHendrik Fokken, Julian Waclawski, Nadine Kattre, et al.
Pageof 28

Showing results (51-60 of 280) with videos related to

Sort By:
Pageof 28
Annals of Hematology|June 27, 2025
Effectiveness of venetoclax based therapy in t(11;14) multiple myeloma with extensive extramedullary disease: a case reportKerstin Brinkert, Bernd Heinrich, Annamaria Brioli, et al.
Annals of Hematology|October 27, 2020
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrowNils W Engel, Jochim Reinert, Nora M Borchert, et al.
GMS Hygiene and Infection Control|November 22, 2018
Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncologyClaas Baier, Christin Linderkamp, Andreas Beilken, et al.
Experimental Hematology|January 26, 2010
Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemiaMichael Heuser, Gyeongsin Park, Yeonsook Moon, et al.
Leukemia & Lymphoma|September 24, 2020
Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel reviewJorge E Cortes, Anna Candoni, Richard E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factorFrederik Damm, Kathrin Lange, Michael Heuser, et al.
Experimental Hematology|April 1, 2008
Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3Bob Argiropoulos, Lars Palmqvist, Eric Yung, et al.
Haematologica|September 2, 2011
Rare occurrence of DNMT3A mutations in myelodysplastic syndromesFelicitas Thol, Claudia Winschel, Andrea Lüdeking, et al.
International Journal of Molecular Sciences|October 24, 2018
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q DeletionSimone Feurstein, Kathrin Thomay, Winfried Hofmann, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 20, 2023
A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemiaHendrik Fokken, Julian Waclawski, Nadine Kattre, et al.
Pageof 28